Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 15, 2019
Pharmacy Choice - News - Drug Delivery Systems - February 15, 2019

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 59     Next >>     Go To Page:

2/15/19 - Bluetooth Will Help IoT Enabled Medical Devices Grow At 29.9% A Year
Global IoT Enabled Healthcare Equipment Market Forecast, Market Size, 2018-2023,$ Billion. LONDON, GREATER LONDON, UK, February 15, 2019/ EINPresswire.com/ Wearable medical devices and diagnostic companies are increasingly integrating Bluetooth wireless technology with medical devices, a new report from The Business Research Company, IoT Enabled.
2/15/19 - IV Infusion Pump Accessories Market to Reach US $2800 Mn by 2025: North America to Witness Increased Adoption of IV Infusion Pump Accessories in the Foreseeable Future
Valley Cottage, NY 02/14/2019 To understand various facets of the global IV infusion pump accessories market, Persistence Market Research has come up with an analytical research publication titled "IV Infusion Pump Accessories Market: Global Industry Analysis and Forecast". The comprehensive IV infusion pump accessories market research report
2/15/19 - Nanotechnology in Drug Delivery 2019 Global Market Share, Trends, Segmentation & Forecast To 2025
Drug Delivery Systems refers to the different Delivery forms of various therapeutic drugs adopted by people in the process of disease prevention and treatment, which were called dosage forms in pharmacy before the 1960 s. Rising demand from Asia-Pacific region a major driver for the growth of the market. In 2017, the global Nanotechnology in Drug D
2/15/19 - New Wave Endo-Surgery Inc. Completes the Acquisition of FDA Cleared Anesthesia Nerve Block Needle Product Line
New Wave Endo-Surgery Inc. announced today that it completed the acquisition of the Acacia Inc. FDA cleared Nerve Block Needle and anesthesia kit product line. New Wave Endo-Surgery Inc. was founded in 2014 to design, and manufacture proprietary medical devices for laparoscopic and robotic surgery. New Wave Endo-Surgery Inc. will be presenting thei
2/15/19 - Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco
Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, today announced the Company will present clinical and health economic outcomes data at the 2019 American Academy of Allergy, Asthma& Immunology Annual Meeting in San Francisco, California, February 22- 25, 2019. Poster 190: Exhalation D
2/15/19 - Pivot Pharma Develops Transdermal Patch for Delivery of CBD and THC
-Pivot Pharmaceuticals Inc. is pleased to announce that the Company has completed the development of a controlled-release transdermal patch system for the delivery of cannabinoids. Joseph Borovsky at Pivot's Contract Laboratory in Israel. Joseph Borovsky, Pivot's Chairman and Executive Vice President, Technology, commented, "I am very pleased to ad
2/15/19 - Spinal Devices Market Emerging Growth by Top Key Players Stryker, Vertiflex Inc., Smith & Nephew, Siemens Healthcare GmbH, RTI Surg: Some of the key players in the global spinal device market include Stryker, Vertiflex Inc., Smith & Nephew, Siemens H
Valley Cottage, NY 02/15/2019 Spinal devices are used in spinal cord injury in order to regain the loss of body sensation such as mobility or feeling. According to the Society of Neurointerventional Surgery, neurointervention is an approach for treatment that occurs within the vessels of brain or with the spinal cavity. In October 2016, the U
2/15/19 - Sterile Injectable Drugs Market to Grow at a Stellar Pace Reflecting a 6.9% CAGR by 2025: Growing Incidence of Cancer and Diabetes and Rapid Increase in Demand for Novel Drug Delivery Systems to Boost Sterile Injectable Drugs Market Growth
New York, NY 02/15/2019 According to the recent market research report published by Persistence Market Research titled' Sterile Injectable Drugs Market: Global Industry Analysis and Forecast', the global sterile injectable drugs is expected to expand at a significant CAGR 6.9% during the forecast period 2017 2025.. Persistence Market Resea
2/14/19 - Controlled Release Drug Delivery Market Poised To Reach $90.18 Billion By 2025: Grand View Research,Inc.
According to report published by Grand View Research, Soaring need for geriatric and pediatric controlled release delivery techniques and alternative therapies and rising awareness regarding benefits of these systems over conventional forms are providing a fillip to the Controlled Release Drug Delivery Market. Asia Pacific is expected to post the..
2/14/19 - Drug Infusion System Market 2019 | Size and Share | By Application - Oncology, Chemotherapy and Forecast to 2023
Market Research Future has released a new report on the Global Drug Infusion System Market which reveals a notable CAGR during the forecast period of 2018 to 2023. November 07, 2018: NantHealth NH, a leader in breakthrough cancer research and solutions has recently announced a collaboration with GE Healthcare, B. Braun Australia, and iProcedures to
2/14/19 - Nasal Drug Delivery Technology Market growing at a CAGR of 6.23% from 2017 to 2025
Planet Market Reports Has Further a Report, Titled, "Global Nasal Drug Delivery Technology Market Skilled Survey Report 2019." The Analysis Offers an Intensive Analysis Of Key Market Dynamics, Market Segmentation, And Competitive ...
2/14/19 - Ocular Drug Delivery Technology Market Complete Survey 2018-2026 Featuring Top Players: OCULAR THERAPEUTIX, Allergan, EyeGate Pharma, Clearside Biomedical: A closer look at the overall Ocular Drug Delivery Technology business scenario presented throu
New York, NY 02/14/2019 The latest report Ocular Drug Delivery Technology discusses everything a business owner needs to know about the Ocular Drug Delivery Technology market for the forecast period, 2018 to 2026. The document offers an insight into what the target customer's needs and wants. The major players covered in this Ocular Drug Deli
2/14/19 - Split-Dosing Regimen Granted FDA Approval for Multiple Myeloma Treatment [Sudan Tribune]
Officials with the FDA have approved a split-dosing regimen for Janssen Pharmaceuticals daratumumab, a therapy used to treat patients with multiple myeloma, according to a press release. The revised label allows for daratumumab to be administered as a split infusion over 2 consecutive days. Daratumumab was first approved in November 2015 as the fir
2/14/19 - t:slim X2 Insulin Pump First to Receive New ACE Pump Classification by FDA
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration has classified the t: slim X2? insulin pump as the first in a new device category called Alternate Controller Enabled Infusion Pumps. This new classification of the t: slim X2 pump provides more fle
2/14/19 - Verastem Oncology Announces Publication of the Phase 2 DYNAMO Study Results in Indolent Non-Hodgkin Lymphoma in the Journal of Clinical Oncology
Verastem, Inc., a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that the results of the Phase 2 DYNAMO? study, which evaluated COPIKTRA? capsules in patients with indolent non-Hodgkin lymphoma who were refractory to both ritux
2/13/19 - Alembic Pharmaceuticals announces Orit Laboratories LLC receives USFDA Approval for Fenofibrate Tablets USP, 54 mg and 160 mg
Alembic Pharmaceuticals Limited today announced that its wholly owned step down subsidiary Orit Laboratories LLC has received approval from the US Food& Drug Administration for its Abbreviated New Drug Application Fenofibrate Tablets USP, 54 mg and 160 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Tricor..
2/13/19 - Breckenridge Pharmaceutical, Inc. - Tetracycline launch announced
Boca Raton- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Tetracycline Capsules. The U.S. Food and Drug Administration had granted final approval for this Abbreviated New Drug Application on November 7, 2018. Breckenridge Pharmaceutical, Inc. is a privately-held own-label distributor that performs pharmaceutical...
2/13/19 - CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR? Technology Targeting Delivery Directly to the Tumor
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, and its private, wholly-owned subsidiary Centurion BioPharma Corporation, today announced the publication of peer reviewed, scientific research for LADR-7, one of its lead LADR? candidates. The article, entitled "Novel auristatin E-based albumin-bi
2/13/19 - Dr. Reddy's Laboratories launches Tadalafil Tablets USP in the U.S. Market
Hyderabad- Dr. Reddy's Laboratories Ltd. today announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca Tablets in the United States market, approved by the U.S. Food and Drug Administration. Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovat
2/13/19 - Drug Infusion System Market 2019 | Size and Share | By Application Oncology, Chemotherapy and Forecast to 2023
"Drug Infusion System Market" Market Research Future has released a new report on the Global Drug Infusion System Market which reveals a notable CAGR during the forecast period of 2018 to 2023. November 07, 2018: NantHealth NH, a leader in breakthrough cancer research and solutions has recently announced a collaboration with GE Healthcare, B. Braun
2/13/19 - Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering
Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today confirmed a broad patient population for its Phase III MicroProst program for the lowering of intraocular pressure. Following discussions with the U.S. Food and Drug...
2/13/19 - Genmab Announces U.S. FDA Approval of DARZALEX (daratumumab) Split Dosing Regimen [Syrian Arab News Agency]
Genmab A/S announced today that the U.S. Food and Drug Administration has approved a split dosing regimen for DARZALEX. In August 2012, Genmab granted Janssen an exclusive worldwide license to develop, manufacture and commercialize daratumumab. We are pleased that, with this change, patients in the U.S. receiving their first infusion of DARZALEX ma
2/13/19 - Genmab Announces U.S. FDA Approval of DARZALEX Split Dosing Regimen
Genmab A/S announced today that the U.S. Food and Drug Administration has approved a split dosing regimen for DARZALEX. The supplemental Biologics License Application was submitted by Genmab's licensing partner, Janssen Biotech, Inc., in July, 2018. 'We are pleased that, with this change, patients in the U.S. receiving their first infusion of DARZA
2/13/19 - Global Prefilled Syringes (Material, Design, Application) Market, 2013-2018 & 2023 - Increasing Adoption of Ready-to-Use Elastomeric Syringe Components by Drug Manufacturers
The "Prefilled Syringes Market by Material, by Design, by Application, by Geography- Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023" report has been added to ResearchAndMarkets.com' s offering. Prefilled syringes market is expected to attain a size of $7.5 billion by 2023, increasing demand for injectable pharmaceutic
2/13/19 - Infusion Pump Market Division, New Business Opportunities, Growth Rate, Development Trend and Feasibility Studies 2023
Infusion Pump Market report, published by Market Research Future contains succinct information on the Infusion Pump Market, segmented by Type- Volumetric Pump, Syringe Pump, Ambulatory Pump& Others. Market Research Future has announced a new release on the Global Infusion Pumps Market. The report predicts the Global Infusion Pumps Market to reach a
Articles(s): 1 - 25 of 59     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415